at Investor's Business Daily (Jan 16, 2015)
United Therapeutics (UTHR): Q3 EPS of $0.66 may not be comparable to consensus of $0.54. Revenue of $171M (+76%) vs. $149M. (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Jan 15, 2015)
at Benzinga.com (Jan 11, 2015)
at Benzinga.com (Jan 6, 2015)
at Benzinga.com (Jan 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs